• 한국식품과학회지
• /
• 제46권5호
• /
• pp.531-537
• /
• 2014

십자화과 채소인 콜라비 및 무에는 glucosinolate 성분이 함유되어 있으며, 특히 새싹 채소의 경우 성숙한 채소보다 glucosinolate의 함량이 더 높은 것으로 알려져 있다. 이와 같은 이유로 최근 새싹채소에 대한 관심은 높으나, 아직 새싹채소에 대한 연구는 미비한 편이다. 따라서 본 연구에서는 십자화과 채소인 콜라비 새싹 추출물(KSE) 및 무순 추출물(RSE)의 total carotenoid 및 glucosinolate의 함량을 분석하였고 이들 추출물의 항산화 및 anti-adipogenic 활성을 평가하였다. KSE의 total carotenoid 및 glucosinolate 함량은 각각 $39.50{\pm}0.67$ 및 $2.65{\pm}0.02mg/g$이며, RSE의 total carotenoid 및 glucosinolate 함량은 각각 $76.73{\pm}2.75$ 및 $8.13{\pm}0.54mg/g$으로 KSE보다 높았다. 다양한 항산화 평가 모델(DPPH, ABTS, FRAP, reducing power)을 통하여 항산화 활성을 측정한 결과, KSE 및 RSE는 농도 의존적으로 항산화 활성이 증가하는 경향을 나타내었다. 또한, 지방세포의 분화과정에서 KSE 및 RSE의 처리는 지방세포의 지방축적 및 ROS 생성을 억제하였으며, KSE 및 RSE의 주요 성분으로 알려진 ${\beta}$-carotene, glucoraphanin 및 glucoraphenin의 처리는 지방 축적 억제 및 ROS 생성 저감 활성을 나타내었다. 이상의 결과로부터, ${\beta}$-carotene, glucoraphanin 및 glucoraphenin이 풍부한 RSE 및 KSE는 항산화 활성 및 지방세포 분화억제 효능을 갖으며, 천연물 유래 항비만 소재로서 활용 가능성이 높은 것으로 기대된다.

• 한국식품저장유통학회지
• /
• 제24권3호
• /
• pp.483-489
• /
• 2017

본 연구에서는 저온 플라즈마를 활용하여 phloridzin을 20, 40 및 60분 동안 처리하여 얻어진 결과물에 대하여 DPPH 라디칼 소거, ${\alpha}$-glucosidase 및 pancreatic lipase 저해활성을 평가하였다. 그 결과, DPPH 라디칼 소거활성은 플라즈마로 처리하지 않은 phloridzin의 $IC_{50}$ 값이 $500{\mu}g/mL$ 이상이었으며, 이와 비교하여 플라즈마 60분 처리 반응물의 경우 $IC_{50}$ 값이 $100.5{\pm}2.9{\mu}g/mL$ 나타내어 항산화 활성이 상승한 것을 확인하였다. 또한 ${\alpha}$-glucosidase 저해활성은 60 분 동안 플라즈마 처리한 phloridzin의 $IC_{50}$ 값이 $43.5{\pm}2.2{\mu}g/mL$의 가장 우수한 저해활성을 나타내었으며 이 활성은 양성대조군인 acarbose의 $IC_{50}$ 값인 $541.3{\pm}1.9{\mu}g/mL$ 보다 10배 이상 강한 활성이었다. Pancreatic lipase 저해활성은 60분 플라즈마를 처리한 phloridzin의 $IC_{50}$ 값이 $29.8{\pm}2.0{\mu}g/mL$로 가장 우수한 활성을 나타내었다. 향후 이들 반응을 통하여 생성된 화합물의 대량생산을 통한 물질 분리 및 구조 동정을 통하여 DPPH 라디칼 소거활성, ${\alpha}$-glucosidase 및 pancreatic lipase 저해활성 메커니즘 검증을 수행할 필요성이 있다고 사료된다.

• 생명과학회지
• /
• 제29권4호
• /
• pp.447-454
• /
• 2019

비만은 에너지의 불균형으로 인하여 체내 지방조직에 지방이 축적되는 대사성질환으로 심혈관계 질환, 고혈압, 2형 당뇨, 고지혈증 및 각종 암의 발생 빈도를 증가시키는 요인이다. 지방의 축적은 지방전구세포가 지방세포로 분화하는 과정을 의미하는 adipogenesis라는 과정을 거쳐서 일어난다. 지방세포로의 분화는 다양한 호르몬과 전사인자들의 상호작용에 의해서 일어난다. 본 연구에서는 팔각회향이 항비만 소재로 활용 가능한지 확인하기 위해, 팔각회향 물 추출물을 분획하여 지방축적 억제 활성이 좋은 dichloromethane층을 선정하였다. 3T3-L1 지방전구세포가 성숙한 지방세포로 분화할 때 팔각회향 dichloromethane 층이 어떠한 기전으로 분화를 조절하는지 확인한 결과, 지방세포 분화에서 중요한 전사인자인 C/EBP family, $PPAR{\gamma}$의 발현이 억제되었고, 지방세포 최종 분화 마커로 알려져 있는 FAS 및 LPL의 발현 또한 감소되었다. 또한 G1기에서의 세포주기 정지를 통해 지방세포 분화 단계에서 필수적인 mitotic clonal expansion 단계를 억제한다는 결과를 얻었다. 이러한 연구 결과는 팔각회향이 항비만 효과를 가지는 천연물 소재로의 활용가능성을 보여주는 기초 자료가 될 것으로 사료된다.

• 한국전문물리치료학회지
• /
• 제26권3호
• /
• pp.67-75
• /
• 2019

Background: Stress urinary incontinence (SUI) is an involuntary leakage of urine from the urethra when intra-abdominal pressure increases, such as from sneezing, coughing, or physical exertion. It is caused by insufficient strength of the pelvic floor and sphincter muscles, resulting from vaginal delivery, obesity, hard physical work, or aging. The pelvic floor electrical stimulator is a conservative treatment generally used to relieve the symptoms of urinary incontinence. it recommended to applied before surgery is performed. Objects: The purpose of this study was to determine if the transcutaneous electrical stimulation (TCES) would be effective for the physiological symptoms and psychological satisfaction of women with SUI for an 8-weeks intervention. Methods: Easy-K is a specially designed user-friendly TCES. Five female who were diagnosed with SUI by a gynecologist but who did not require surgical intervention were included in this study. Intervention was implemented over an 8-week period. Outcome measures included vaginal ultrasonography, Levator ani muscle (LAM) contraction strength, incontinence quality of life (I-QOL), and female sexual function index (FSFI) questionnaires. Results: The bladder neck position significantly decreased across assessment time. Funneling index and urethral width significantly decreased after 8 weeks of intervention (p<.05). The bladder necksymphyseal distance and posterior rhabdosphincter thickness statistically increased and the anterior rhabdosphincter thickness showed a tendency to increase. All participants demonstrated a significant increase in the LAM contraction score across three assessment times (p<.05). Although the total score of the I-QOL did not show significant improvement, it steadily increased and among I-QOL subscales, only the "avoidance" subscale showed statistical improvements (p<.05). The total score of the FSFI statistically improved and the "desire" score significantly changed (p<.05). Conclusion: The TCES is recommended for women who want to apply conservative treatments before surgery and who have suffered from SUI in aspects of sexual function and quality of life.

• 한국자원식물학회지
• /
• 제34권2호
• /
• pp.186-196
• /
• 2021

본 연구는 유지효모 R. toruloides를 활용하여 적색 파프리카 추출물의 중성지방 억제 효과를 확인하기 위하여 수행되었다. 대조구, 양성대조구, 0.02, 0.1 및 0.5% 적색 파프리카 70% 에탄올 추출물을 첨가한 실험구의 총 지질 함량은 각각 80.45±2.40, 86.61±11.58, 79.82±2.80, 85.30±0.91 및 92.40±12.40 mg/g으로 나타났으며, 유지효모의 중성지방 함량은 각각9.89±0.36, 7.58±1.11, 7.28±0.17, 6.68±0.35 및 5.23±0.67 mg/dL으로 나타났다. 대조구, 양성대조구, 0.02, 0.1 및 0.5% 적색 파프리카 70% 에탄올 추출물을 첨가한 실험구의 지방소적 형성을 관찰한 결과, 적색 파프리카 70% 에탄올 추출물의 첨가농도가 증가함에 따라 대조구에 비해 소량의 형광이 관찰되는 것으로 보아 유지효모 내 생성되는 지방소적이 감소됨을 확인하였다. 대조구, 양성대조구, 0.02, 0.1 및 0.5% 적색 파프리카 70% 에탄올 추출물을 첨가한 실험구의 세포수는 각각 1.90±0.16, 2.17±0.25, 1.85±0.11, 2.28±0.21 및 2.49±0.03×10⁸ cell/mL으로 나타났으며, 유리지방산의 함량은 각각2.44±0.05, 2.71±0.07, 2.46±0.16, 2.52±0.10 및 2.98±0.14 mg/g으로 나타났다. 본 연구결과에서 적색 파프리카 70% 에탄올 추출물의 첨가농도에 따른 유지효모 내 중성지방 억제 효과, 지방소적의 감소, 세포수 및 유리지방산의 함량이 증가한 결과를 통해 적색 파프리카 70% 에탄올 추출물이 중성지방 억제 효과에 유의적인 영향을 미치는 것으로 확인되었으며, 추후 활성 물질의 규명에 관한 추가적인 연구가 필요할 것으로 사료된다.

• Journal of Ginseng Research
• /
• 제45권1호
• /
• pp.48-57
• /
• 2021

Background: Ginsenoside Rh2 is well known for many pharmacological activities, such as anticancer, antidiabetes, antiinflammatory, and antiobesity properties. Glycosyltransferases (GTs) are ubiquitous enzymes present in nature and are widely used for the synthesis of oligosaccharides, polysaccharides, glycoconjugates, and novel derivatives. We aimed to synthesize new ginsenosides from Rh2 using the recombinant GT enzyme and investigate its cytotoxicity with diverse cell lines. Methods: We have used a GT gene with 1,224-bp gene sequence cloned from Lactobacillus rhamnosus (LRGT) and then expressed in Escherichia coli BL21 (DE3). The recombinant GT protein was purified and demonstrated to transform Rh2 into two novel ginsenosides, and they were characterized by nuclear magnetic resonance (NMR) techniques and evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assay. Results: Two novel ginsenosides with an additional glucopyranosyl (6→1) and two additional glucopyranosyl (6→1) linked with the C-3 position of the substrate Rh2 were synthesized, respectively. Cell viability assay in the lung cancer (A549) cell line showed that glucosyl ginsenoside Rh2 inhibited cell viability more potently than ginsenoside Rg3 and Rh2 at a concentration of 10 μM. Furthermore, glucosyl ginsenoside Rh2 did not exhibit any cytotoxic effect in murine macrophage cells (RAW264.7), mouse embryo fibroblasts cells (3T3-L1), and skin cells (B16BL6) at a concentration of 10 μM compared with ginsenoside Rh2 and Rg3. Conclusion: This is the first report on the synthesis of two novel ginsenosides, namely, glucosyl ginsenoside Rh2 and diglucosyl ginsenoside Rh2 from Rh2 by using recombinant GT isolated from L. rhamnosus. Moreover, diglucosyl ginsenoside Rh2 might be a new candidate for treatment of inflammation, obesity, and skin whiting, and especially for anticancer.

• Nutrition Research and Practice
• /
• 제16권1호
• /
• pp.14-32
• /
• 2022

BACKGROUND/OBJECTIVES: Peroxisome proliferator-activated receptor-gamma co-activator-1α (PGC-1α) has a central role in regulating muscle differentiation and mitochondrial metabolism. PGC-1α stimulates muscle growth and muscle fiber remodeling, concomitantly regulating lactate and lipid metabolism and promoting oxidative metabolism. Gynostemma pentaphyllum (Thumb.) has been widely employed as a traditional herbal medicine and possesses antioxidant, anti-obesity, anti-inflammatory, hypolipemic, hypoglycemic, and anticancer properties. We investigated whether G. pentaphyllum extract (GPE) and its active compound, gypenoside L (GL), affect muscle differentiation and mitochondrial metabolism via activation of the PGC-1α pathway in murine C2C12 myoblast cells. MATERIALS/METHODS: C2C12 cells were treated with GPE and GL, and quantitative reverse transcription polymerase chain reaction and western blot were used to analyze the mRNA and protein expression levels. Myh1 was determined using immunocytochemistry. Mitochondrial reactive oxygen species generation was measured using the 2'7'-dichlorofluorescein diacetate assay. RESULTS: GPE and GL promoted the differentiation of myoblasts into myotubes and elevated mRNA and protein expression levels of Myh1 (type IIx). GPE and GL also significantly increased the mRNA expression levels of the PGC-1α gene (Ppargc1a), lactate metabolism-regulatory genes (Esrra and Mct1), adipocyte-browning gene fibronectin type III domain-containing 5 gene (Fndc5), glycogen synthase gene (Gys), and lipid metabolism gene carnitine palmitoyltransferase 1b gene (Cpt1b). Moreover, GPE and GL induced the phosphorylation of AMP-activated protein kinase, p38, sirtuin1, and deacetylated PGC-1α. We also observed that treatment with GPE and GL significantly stimulated the expression of genes associated with the anti-oxidative stress response, such as Ucp2, Ucp3, Nrf2, and Sod2. CONCLUSIONS: The results indicated that GPE and GL enhance exercise performance by promoting myotube differentiation and mitochondrial metabolism through the upregulation of PGC-1α in C2C12 skeletal muscle.

• Journal of Ginseng Research
• /
• 제46권6호
• /
• pp.780-789
• /
• 2022

Background: Incretin impairment, characterized by insufficient secretion of L-cell-derived glucagon-like peptide-1 (GLP-1), is a defining step of type 2 diabetes mellitus (T2DM). Ginsenoside compound K (CK) can stimulate GLP-1 secretion; however, the potential mechanism underlying this effect has not been established. Methods: CK (40 mg/kg) was administered orally to male db/db mice for 4 weeks. The body weight, oral glucose tolerance, GLP-1 secretion, gut microbiota sequencing, bile acid (BA) profiles, and BA synthesis markers of each subject were then analyzed. Moreover, TGR5 expression was evaluated by immunoblotting and immunofluorescence, and L-cell lineage markers involved in L-cell abundance were analyzed. Results: CK ameliorated obesity and impaired glucose tolerance in db/db mice by altering the gut microbiota, especially Ruminococcaceae family, and this changed microbe was positively correlated with secondary BA synthesis. Additionally, CK treatment resulted in the up-regulation of CYP7B1 and CYP27A1 and the down-regulation of CYP8B1, thereby shifting BA biosynthesis from the classical pathway to the alternative pathway. CK altered the BA pool by mainly increasing LCA and DCA. Furthermore, CK induced L-cell number expansion leading to enhanced GLP-1 release through TGR5 activation. These increases were supported by the upregulation of genes governing GLP-1 secretion and L-cell differentiation. Conclusions: The results indicate that CK improves glucose homeostasis by increasing L-cell numbers, which enhances GLP-1 release through a mechanism partially mediated by the gut microbiota-BA-TGR5 pathway. Therefore, that therapeutic attempts with CK might be useful for patients with T2DM.

• 대한정형외과학회지
• /
• 제55권2호
• /
• pp.117-126
• /
• 2020

슬관절의 퇴행성 관절염에서 슬관절 전치환술은 널리 시행되고 있고 그 빈도도 점점 증가되고 있다. 수술 후 일상생활로의 복귀, 근력 및 운동범위의 회복 등 기능 회복을 위한 노력이 이루어져야 하고 이는 환자 요인, 수술 술기 및 재활 등 다양한 관점에서 접근해야 한다. 환자의 연령이나 비만의 정도, 성별, 대퇴사두근의 근력 등이 수술 후 기능 회복에 영향을 줄 수 있고 환자의 기대치나 만족도 같은 정신적인 상태도 영향을 준다. 기능 회복을 위하여 수술 전부터 환자교육 및 통증 조절, 대퇴사두근 근력의 강화 같은 치료를 시행할 수 있다. 수술 후 냉찜질 및 압박, 경피적 전기 신경 자극 치료, 신경근육 전기 자극 치료, 저주파 저강도 자기장 치료, 대퇴사두근의 근력운동, 관절범위 운동과 같은 물리치료도 적용할 수 있다. 최근에는 수중에서 근력과 균형감각을 회복시키는 수 치료도 점점 시행되는 추세이다. 이런 기능 회복을 위한 치료들은 수술 후 단기적으로만 시행될게 아니라 장기적으로 꾸준히 시행되는 것이 중요하며 술자는 환자의 상태나, 순응도, 사회적, 심리적 상황 등을 고려하여 적절히 적용하여야 한다.

• Nutrition Research and Practice
• /
• 제16권1호
• /
• pp.60-73
• /
• 2022

BACKGROUND/OBJECTIVES: The extract from Dendropanax morbifera exhibited diverse therapeutic potentials. We aimed to evaluate the efficacy and safety of D. morbifera leaf extract for improving metabolic parameters in human. SUBJECTS/METHODS: A 12-week, double blind, placebo-controlled and randomized trial included a total of 74 adults, and they were assigned to the placebo group (n = 38) or 700 mg/day of D. morbifera group (n = 36). The efficacy endpoints were changes in glycemic, lipid, obesity, and blood pressure (BP) parameters, in addition to the prevalence of metabolic syndrome (MetS) and the numbers of MetS components. Safety was assessed by monitoring adverse events (AEs). RESULTS: After 12 weeks of treatment, the hemoglobin A1c (HbA1c) level significantly decreased in the D. morbifera group compared to that of the placebo group (difference: -0.13 ± 0.20% vs. 0.00 ± 0.28%, P = 0.031; % of change: -2.27 ± 3.63% vs. 0.10 ± 5.10%, P = 0.025). The homeostatic model assessment for insulin resistance level also decreased significantly from its baseline in the D. morbifera group. The systolic BP of D. morbifera group decreased significantly than that of placebo group (difference: -3.9 ± 9.8 mmHg vs. 3.3 ± 11.7 mmHg, P = 0.005; % of change: -2.8 ± 7.7% vs. 3.3 ± 10.2%, P = 0.005). However, the lipid parameters and body composition including body weight did not differ between the groups. The prevalence of MetS (36.8% vs. 13.9%, P = 0.022) and the incidence of MetS (10.5% vs. 13.9%, P = 0.027) at 12 weeks was significantly lower in the D. morbifera group than it was in the placebo group. No serious AEs occurred in either group. CONCLUSIONS: Supplementation with D. morbifera extracts over a 12-week period improved metabolic parameters such as HbA1c and BP and reduced the prevalence of MetS.